UPDATE: Cantor Fitzgerald Upgrades Collegium Pharmaceutical (COLL) to Buy
Tweet Send to a Friend
(Updated - February 14, 2022 4:03 PM EST)
Cantor Fitzgerald analyst Brandon Folkes upgraded Collegium Pharmaceutical (NASDAQ: COLL) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cantor Fitzgerald analyst Brandon Folkes upgraded Collegium Pharmaceutical (NASDAQ: COLL) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
